Menopause, hormone replacement and heart health: New Canadian guidelines – CTV
Nov. 1, 2022
New guidelines informing the care of perimenopausal and post-menopausal woman in Canada have been released, backed by new data to help physicians know when to prescribe menopausal hormone therapy — and when it might not be worth potential risks.
Post-menopause, women are at a higher risk for a number of health conditions, including cardiovascular disease. Doctors want to ensure any treatment a patient undergoes due to menopause doesn’t increase those risks even further.
The updated guidelines state that menopausal hormone therapy is the most effective treatment for the relief of menopause symptoms.
Researchers found that long-term data showed that short-term menopausal hormone therapy did not come with increased cardiovascular risk when appropriately prescribed to women who were not at a high risk for heart problems.
